GO:0032663 regulation of interleukin-2 production: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032663 (regulation of interleukin-2 production) is a biological process that modulates the frequency, rate, or extent of interleukin-2 (IL-2) production, encompassing transcriptional, post-transcriptional, and secretory control.
• IL-2 is a pleiotropic cytokine essential for T cell proliferation, survival, and effector function, and its production is tightly regulated by T cell receptor (TCR) and CD28 co-stimulation signals.
• Dysregulated IL-2 production is implicated in autoimmune diseases such as rheumatoid arthritis, where synovial mononuclear cells show altered IL-2 regulation.
• IL-2 also regulates tumor-reactive CD8+ T cell exhaustion via the aryl hydrocarbon receptor, linking IL-2 production to cancer immunotherapy outcomes.
• CRISPR activation and interference screens in primary human T cells have decoded stimulation-dependent regulatory networks controlling IL-2 and other cytokine responses.
• Engineered probiotics delivering IL-2 represent a novel therapeutic strategy for inflammatory bowel disease, highlighting the translational importance of IL-2 regulation.
Description
Regulation of interleukin-2 production (GO:0032663) is a fundamental biological process that controls the synthesis and secretion of interleukin-2 (IL-2), a cytokine critical for T lymphocyte proliferation, survival, and effector functions. IL-2 was originally identified as a T cell growth factor, and its production is exquisitely regulated at multiple levels to ensure appropriate immune responses while preventing autoimmunity. The process encompasses transcriptional activation of the IL2 gene, post-transcriptional mRNA stabilization, and secretion of the mature protein. Understanding how IL-2 production is regulated is essential for immunology research, as perturbations in this process contribute to autoimmune diseases, immunodeficiency, and cancer. Recent advances in CRISPR screening technologies have enabled systematic dissection of the regulatory networks governing IL-2 production in primary human T cells, revealing novel modulators and potential therapeutic targets. This article provides a comprehensive overview of GO:0032663, integrating authoritative GO annotations with published literature to support researchers studying IL-2 regulation and its role in health and disease.
regulation of interleukin-2 production At A Glance
| GO ID | GO:0032663 |
|---|---|
| GO term | regulation of interleukin-2 production |
| Ontology | biological_process |
| Synonym | regulation of IL-2 production; regulation of interleukin-2 biosynthetic process; regulation of interleukin-2 secretion |
| Major function | Modulates the frequency, rate, or extent of interleukin-2 production, affecting T cell activation, proliferation, and immune homeostasis |
| Related cytokines | Interleukin-2 (IL-2), a pleiotropic cytokine primarily produced by activated CD4+ and CD8+ T cells |
| Key signaling pathways | TCR signaling, CD28 co-stimulation, NF-kB, NFAT, AP-1, and mTOR pathways |
| Disease relevance | Autoimmune diseases (e.g., rheumatoid arthritis), cancer immunotherapy, inflammatory bowel disease |
| Research methods | CRISPR screens, RNA-seq, flow cytometry, ELISA, reporter assays |
What Is GO:0032663?
According to the Gene Ontology, GO:0032663 (regulation of interleukin-2 production) is defined as any process that modulates the frequency, rate, or extent of interleukin-2 production. This biological process includes mechanisms that control the biosynthesis, secretion, or overall availability of IL-2, a key cytokine in immune regulation. The term encompasses both positive and negative regulation, integrating signals from cell surface receptors, intracellular signaling cascades, and transcriptional or post-transcriptional regulators.
Why Is regulation of interleukin-2 production Important in Cell Biology?
Regulation of interleukin-2 production is critically important because IL-2 serves as a central hub in immune responses, controlling T cell expansion, differentiation, and tolerance. Precise regulation ensures effective pathogen clearance while preventing excessive inflammation or autoimmunity. Dysregulation of IL-2 production is associated with autoimmune disorders such as rheumatoid arthritis, where synovial mononuclear cells exhibit altered IL-2 regulation. In cancer, IL-2 influences CD8+ T cell exhaustion and immunotherapy efficacy, making its regulation a target for therapeutic intervention. Furthermore, engineered IL-2 delivery systems are being developed for inflammatory bowel disease, underscoring the clinical relevance of understanding and manipulating IL-2 production. Advances in CRISPR screening have provided powerful tools to identify novel regulators of IL-2 production, accelerating discovery of new drug targets.
• IL-2 is essential for T cell proliferation, survival, and effector function, making its regulation central to adaptive immunity.
• CD28 co-stimulation is a critical regulator of IL-2 gene enhancer activity and production.
• Dysregulated IL-2 production contributes to autoimmune diseases such as rheumatoid arthritis.
• IL-2 regulates tumor-reactive CD8+ T cell exhaustion via the aryl hydrocarbon receptor, impacting cancer immunotherapy.
• Engineered probiotics releasing IL-2 show promise for treating inflammatory bowel disease.
• CRISPR activation and interference screens in primary human T cells have identified novel regulators of IL-2 production.
• IL-2-mediated NF-kB-dependent mRNA splicing modulates interferon gamma production, linking IL-2 to broader cytokine networks.
• Understanding IL-2 regulation aids in designing vaccines and immunotherapies that optimize T cell responses.
• Molecular regulation of IL-2 expression by CD28 co-stimulation and anergy provides insights into T cell tolerance.
• IL-2 production is a key readout in functional genomics screens for immune cell engineering.
What Happens During regulation of interleukin-2 production?
T cell receptor and co-stimulatory signaling
In simple terms: When a T cell recognizes a foreign peptide, it receives signals that turn on the IL-2 gene.
Regulation of IL-2 production begins with T cell receptor (TCR) engagement by antigen-MHC complexes, which activates intracellular signaling cascades including calcium flux, PKC activation, and Ras-MAPK pathways. Full IL-2 production requires a second signal through co-stimulatory molecules such as CD28, which enhances IL-2 gene enhancer activity and stabilizes mRNA. CD28 co-stimulation activates PI3K-Akt and NF-kB pathways, leading to robust IL-2 transcription. Without co-stimulation, T cells become anergic and fail to produce IL-2, a mechanism of peripheral tolerance.
Transcriptional activation of the IL2 gene
In simple terms: Special proteins bind to the IL-2 gene and switch it on.
Upon TCR and CD28 stimulation, transcription factors including NFAT, AP-1, and NF-kB translocate to the nucleus and bind the IL2 promoter and enhancer regions. CD28 co-stimulation specifically enhances the activity of the IL-2 gene enhancer, which contains binding sites for NF-kB and other factors. This coordinated transcriptional activation leads to rapid and transient IL-2 mRNA synthesis. Post-transcriptional mechanisms, including mRNA stabilization and splicing, further modulate IL-2 production levels.
Post-transcriptional and splicing regulation
In simple terms: After the gene is turned on, the RNA message can be modified to control how much protein is made.
IL-2 production is also regulated post-transcriptionally. IL-2 signaling itself can induce NF-kB-dependent mRNA splicing changes that modulate interferon gamma production, indicating crosstalk between cytokine pathways. Additionally, mRNA stability elements in the 3' untranslated region of IL2 transcripts influence the duration and magnitude of IL-2 production. These mechanisms ensure that IL-2 production is tightly controlled and transient, preventing prolonged immune activation.
Secretion and feedback regulation
In simple terms: The produced IL-2 is released from the cell and can signal back to regulate its own production.
Newly synthesized IL-2 is secreted through the classical secretory pathway and acts on T cells in an autocrine or paracrine manner. IL-2 binding to its receptor (IL-2R) triggers JAK-STAT signaling, which can further modulate T cell responses and IL-2 production. Negative feedback mechanisms, including the induction of regulatory T cells and consumption of IL-2, help terminate the response. Dysregulation of these feedback loops can lead to pathological immune activation, as seen in autoimmune diseases.
Metabolic and environmental modulation
In simple terms: The cell's metabolic state and surroundings can affect how much IL-2 is made.
Cellular metabolism and environmental cues influence IL-2 production. For example, the aryl hydrocarbon receptor (AhR) pathway, activated by environmental ligands, regulates IL-2-driven CD8+ T cell exhaustion. Additionally, engineered probiotics that release IL-2 in the gut demonstrate that local environmental factors can modulate IL-2 availability and immune responses. These findings highlight the integration of metabolic and environmental signals in the regulation of IL-2 production.
Key Genes Involved in GO:0032663 regulation of interleukin-2 production
The following genes and proteins are key players in the regulation of interleukin-2 production, based on published literature and their roles in immune signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2 | Encodes interleukin-2 cytokine | Central to regulation of IL-2 production; target for knockout and overexpression studies |
| CD28 | Co-stimulatory receptor on T cells | Enhances IL-2 gene enhancer activity and production |
| NFKB1 | Transcription factor subunit | Mediates CD28 and TCR-induced IL-2 transcription |
| NFATC1 | Transcription factor | Binds IL2 promoter upon calcium signaling |
| FOS | AP-1 transcription factor component | Cooperates with NFAT to activate IL2 transcription |
| JUN | AP-1 transcription factor component | Cooperates with NFAT to activate IL2 transcription |
| AHR | Aryl hydrocarbon receptor | Regulates IL-2-driven CD8+ T cell exhaustion |
| IL2RA | IL-2 receptor alpha chain (CD25) | Binds IL-2 and mediates feedback signaling |
| IL2RB | IL-2 receptor beta chain (CD122) | Signals via JAK-STAT pathway |
| IL2RG | Common gamma chain | Shared receptor subunit for IL-2 family cytokines |
| STAT5A | Signal transducer and activator of transcription | Mediates IL-2 receptor signaling |
| STAT5B | Signal transducer and activator of transcription | Mediates IL-2 receptor signaling |
| JAK1 | Janus kinase | Phosphorylates STAT proteins downstream of IL-2R |
| JAK3 | Janus kinase | Phosphorylates STAT proteins downstream of IL-2R |
| PIK3CA | PI3K catalytic subunit | Mediates CD28 co-stimulation signals |
| AKT1 | Serine/threonine kinase | Downstream of PI3K in CD28 signaling |
| MTOR | Mechanistic target of rapamycin | Integrates metabolic signals to regulate T cell activation and IL-2 production |
How Is regulation of interleukin-2 production Regulated?
Regulation of IL-2 production is controlled by multiple intracellular and extracellular factors. TCR and CD28 co-stimulation provide the primary activation signals, activating NFAT, AP-1, and NF-kB transcription factors that drive IL2 gene expression. The PI3K-Akt-mTOR pathway integrates metabolic and growth signals to sustain T cell activation and IL-2 production. Negative regulators, including anergy-inducing pathways and regulatory T cells, suppress IL-2 production to maintain tolerance. Post-transcriptional mechanisms, such as mRNA splicing and stability, further fine-tune IL-2 levels. Additionally, environmental factors like AhR ligands can modulate IL-2 responses in CD8+ T cells.
regulation of interleukin-2 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL2 | Rheumatoid arthritis; autoimmune inflammation | Knockout mice, human T cell lines, synovial fluid mononuclear cells |
| AHR | Cancer immunotherapy; T cell exhaustion | CD8+ T cell exhaustion models, AHR knockout mice |
| IL2RA | Autoimmunity; immunodeficiency | Knock-in mice, human T cell lines |
| IL2RB | Inflammatory bowel disease; immune dysregulation | Engineered probiotic models, colitis mouse models |
| NFKB1 | Chronic inflammation; cancer | CRISPR knockout in primary human T cells |
Rheumatoid arthritis
Dysregulated IL-2 production is observed in rheumatoid arthritis, where mononuclear cells from synovial fluids exhibit altered regulation of IL-2 production compared to peripheral blood cells. This suggests that the inflammatory microenvironment in joints modulates IL-2 regulatory pathways, contributing to disease pathogenesis.
Cancer immunotherapy
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor, which affects the efficacy of cancer immunotherapies. Understanding how IL-2 production is regulated in the tumor microenvironment can inform strategies to enhance T cell persistence and anti-tumor activity.
Inflammatory bowel disease
Engineered probiotics with sustained release of IL-2 have been developed for the treatment of inflammatory bowel disease after oral delivery, demonstrating the therapeutic potential of modulating IL-2 availability in mucosal tissues. This approach leverages the regulatory effects of IL-2 on intestinal immune homeostasis.
From regulation of interleukin-2 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of a candidate gene affect IL-2 production? | CRISPR knockout in primary human T cells or Jurkat cells |
| Does a specific point mutation in IL2 promoter alter transcription? | Point mutation knock-in via CRISPR in T cell lines |
| Can a tagged IL-2 protein be used to track secretion? | Knock-in of fluorescent or epitope tag at IL2 locus |
| Does overexpression of a regulator enhance IL-2 production? | CRISPR activation (CRISPRa) or lentiviral overexpression |
| Which genes regulate IL-2 production under stimulation? | Genome-wide CRISPR interference (CRISPRi) screens |
| Can engineered probiotics deliver IL-2 in vivo? | Oral probiotic administration in colitis mouse models |
How to Study the regulation of interleukin-2 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR activation/interference screens | Genes regulating IL-2 production | Discovery of novel regulators in primary T cells |
| RNA-seq | IL2 mRNA levels and splicing | Transcriptional profiling after stimulation |
| ELISA | Secreted IL-2 protein | Quantification of cytokine production |
| Flow cytometry | Intracellular IL-2 and surface markers | Single-cell analysis of T cell responses |
| ChIP-seq | Transcription factor binding at IL2 locus | Mapping regulatory elements |
| Reporter assays | IL2 promoter activity | High-throughput screening of modulators |
| Proliferation assays | IL-2 bioactivity | Functional assessment of IL-2 production |
| Phospho-STAT5 flow | IL-2 receptor signaling | Downstream signaling analysis |
CRISPR screens for IL-2 regulators
CRISPR activation and interference screens in primary human T cells enable systematic discovery of genes that positively or negatively regulate IL-2 production upon stimulation. These screens couple guide RNA libraries with cytokine readouts such as flow cytometry or ELISA to identify novel regulators.
Transcriptional and post-transcriptional analysis
RNA-seq and quantitative RT-PCR can measure IL2 mRNA levels and splicing variants following T cell stimulation. Chromatin immunoprecipitation (ChIP) assays identify transcription factor binding at the IL2 promoter and enhancer.
Protein-level detection of IL-2
ELISA, intracellular cytokine staining, and flow cytometry are standard methods to quantify IL-2 protein production and secretion from activated T cells. Reporter cell lines expressing fluorescent proteins under the IL2 promoter enable high-throughput screening.
Functional assays for IL-2 bioactivity
IL-2 bioactivity can be assessed using T cell proliferation assays, STAT5 phosphorylation flow cytometry, or reporter cell lines. These assays measure the downstream effects of IL-2 production and signaling.
How CRISPR Can Be Used to Study GO:0032663 regulation of interleukin-2 production
Knockout
CRISPR knockout of candidate genes in primary human T cells or Jurkat cells can determine whether a gene is required for IL-2 production. For example, knocking out NFKB1 or CD28 reduces IL-2 production upon stimulation. Knockout models are essential for validating hits from CRISPR screens.
Point Mutation
Point mutations can be introduced into the IL2 promoter or enhancer to dissect specific transcription factor binding sites. For instance, mutating NF-kB binding sites in the IL-2 enhancer abolishes CD28-mediated enhancement of IL-2 production. CRISPR base editing enables precise point mutations without double-strand breaks.
Knock-in
Knock-in of reporter genes (e.g., fluorescent proteins) or epitope tags at the IL2 locus allows real-time tracking of IL-2 production and secretion. Tagged IL-2 can be used for imaging or proteomic studies to understand its trafficking and interactions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive supra-physiological expression of candidate regulators to test sufficiency for IL-2 production. Overexpression of CD28 or NF-kB subunits enhances IL-2 production in T cell lines.
How EDITGENE Supports regulation of interleukin-2 production Research
Researchers studying regulation of interleukin-2 production-related genes often need to determine whether a candidate gene is causally involved in IL-2 regulation or is merely correlated with T cell activation. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic manipulation and functional validation in immune cells.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-2 production research.
Frequently Asked Questions About regulation of interleukin-2 production
What is GO:0032663?
GO:0032663 is the Gene Ontology term for regulation of interleukin-2 production, defined as any process that modulates the frequency, rate, or extent of interleukin-2 production.
What genes are involved in regulation of interleukin-2 production?
Key genes include IL2, CD28, NFKB1, NFATC1, FOS, JUN, AHR, IL2RA, IL2RB, IL2RG, STAT5A, STAT5B, JAK1, JAK3, PIK3CA, AKT1, and MTOR.
How is IL-2 production regulated in T cells?
IL-2 production is regulated by TCR and CD28 co-stimulation, which activate transcription factors like NFAT, AP-1, and NF-kB, as well as post-transcriptional mechanisms.
What diseases are associated with dysregulated IL-2 production?
Dysregulated IL-2 production is associated with rheumatoid arthritis, cancer immunotherapy responses, and inflammatory bowel disease.
How can CRISPR screens identify regulators of IL-2 production?
CRISPR activation and interference screens in primary human T cells can systematically perturb genes and measure IL-2 production to identify positive and negative regulators.
What is the role of CD28 in IL-2 production?
CD28 co-stimulation enhances IL-2 gene enhancer activity and is required for optimal IL-2 production in T cells.
Does IL-2 regulate its own production?
IL-2 signaling through its receptor can modulate T cell responses and indirectly influence IL-2 production via feedback mechanisms.
What methods are used to study regulation of IL-2 production?
Common methods include CRISPR screens, RNA-seq, ELISA, flow cytometry, ChIP-seq, and reporter assays.
What is the role of aryl hydrocarbon receptor in IL-2 regulation?
The aryl hydrocarbon receptor regulates IL-2-driven CD8+ T cell exhaustion, linking environmental signals to IL-2 responses.
Can engineered probiotics deliver IL-2 for therapy?
Yes, engineered probiotics with sustained release of IL-2 have been developed for treating inflammatory bowel disease after oral delivery.
Conclusion
Regulation of interleukin-2 production (GO:0032663) is a critical biological process that governs T cell activation, proliferation, and immune homeostasis. Dysregulation of this process contributes to autoimmune diseases, cancer, and inflammatory disorders, making it a key area of immunological research. Advances in CRISPR screening and functional genomics have provided powerful tools to dissect the regulatory networks controlling IL-2 production, revealing novel therapeutic targets. Continued research into the molecular mechanisms of IL-2 regulation will inform the development of targeted immunotherapies and precision medicine approaches for immune-related diseases.
References
- 1. Schmidt R et al.. 2022. CRISPR activation and interference screens decode stimulation responses in primary human T cells.. Science 375(6580):eabj4008 PMID: 35113687
- 2. Li M et al.. 2024. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.. Biomaterials 309:122584 PMID: 38735180
- 3. Liu Y et al.. 2021. IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor.. Nat Immunol 22(3):358-369 PMID: 33432230
- 4. Gaffen SL et al.. 2004. Overview of interleukin-2 function, production and clinical applications.. Cytokine 28(3):109-23 PMID: 15473953
- 5. Powell JD et al.. 1998. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy.. Immunol Rev 165:287-300 PMID: 9850868
- 6. Van Gelder RD et al.. 2025. Interleukin-2-mediated NF-κB-dependent mRNA splicing modulates interferon gamma protein production.. EMBO Rep 26(1):16-35 PMID: 39578552
- 7. Flescher E et al.. 1992. Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids.. Clin Exp Immunol 87(3):435-7 PMID: 1544227
- 8. Fraser JD et al.. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.. Science 251(4991):313-6 PMID: 1846244
